Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease

Transplant Proc. 2000 Aug;32(5):1032-3. doi: 10.1016/s0041-1345(00)01100-3.
No abstract available

MeSH terms

  • Abatacept
  • Animals
  • Antigens, CD
  • Antigens, Differentiation / therapeutic use*
  • B-Lymphocytes / immunology
  • Bone Marrow Transplantation / immunology*
  • CTLA-4 Antigen
  • Cricetinae
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control*
  • Immunoconjugates*
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Lymphocyte Activation
  • Rats
  • Rats, Inbred Lew
  • Splenectomy
  • T-Lymphocytes / immunology
  • Time Factors
  • Transplantation, Heterologous / immunology*
  • Whole-Body Irradiation

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • Ctla4 protein, rat
  • Immunoconjugates
  • Immunosuppressive Agents
  • Abatacept